Hutch News
Results per Page:
Is the microbiome a springboard or barrier to effective vaccination?
From the Kublin Lab, Vaccine and Infectious Disease Division
Mosaic HIV immunogens boost the breadth of vaccine immune responses
From the Gilbert and McElrath Labs, Vaccine and Infectious Disease Division
Vaccination after CAR-T-cell therapy
From the Hill group, Vaccine and Infectious Disease Division and the UW/Fred Hutch Cancer Consortium
SARS-CoV-2 variants of concern break through vaccination barriers
From the University of Washington and the Fred Hutch Vaccine and Infectious Disease Division
New study finds many cancer patients have no antibodies to measles or mumps
Hospital study shows younger adults, stem cell transplant recipients more likely to have less protection
Easing parents’ HPV vaccine hesitancy with a communication experiment
From the Shah Group, Division of Public Health Sciences
Measles and cancer patients. What to do?
Measles seldom crossed paths with cancer survivors, but now that may change
HPV vaccine uptake highest in Hispanic, low-income communities
Where you live matters for cancer-preventing shot, new study suggests
‘It’s been an incredible ride’
Dr. Denise Galloway reflects on a career — and a life — touched by cancer
U.S. public health funding steadily falling, new study shows
$40 billion loss of funds since 2009 — and it’s already making a difference to our health, say Fred Hutch experts
15 ways to reduce your cancer risk
Fred Hutch's Dr. Anne McTiernan offers tips on what you can do to help protect your health